동물용 의약품 조제 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Animal Drug Compounding Market size is expected to reach USD 6.70 Billion in 2034 from USD 3.10 Billion (2025) growing at a CAGR of 8.93% during 2026-2034.

The animal drug compounding market is experiencing a notable surge, driven by the increasing demand for personalized veterinary care and the growing prevalence of chronic diseases in pets and livestock. As pet ownership rises and animal health awareness grows, veterinarians are increasingly turning to compounding pharmacies to create tailored medications that meet the specific needs of individual animals. This trend is particularly significant in cases where commercially available drugs may not be suitable due to dosage, formulation, or flavor preferences. The ability to customize medications enhances treatment efficacy and compliance, positioning the animal drug compounding market as a vital component of modern veterinary practice.

Furthermore, advancements in pharmaceutical technology and regulatory frameworks are facilitating the growth of the animal drug compounding market. The introduction of more stringent quality standards and guidelines is ensuring that compounded medications are safe, effective, and reliable. As veterinary professionals become more educated about the benefits of compounded drugs, the market is likely to expand, with an increasing number of veterinary practices incorporating compounding services into their offerings. Additionally, the rise of telemedicine in veterinary care is creating new opportunities for compounding pharmacies to reach a broader clientele, allowing for remote consultations and customized medication delivery.

The animal drug compounding market is also witnessing innovation in formulation techniques, with a focus on developing new delivery methods that enhance the palatability and efficacy of medications. The incorporation of flavoring agents, transdermal delivery systems, and sustained-release formulations are just a few examples of how compounding pharmacies are adapting to meet the evolving needs of veterinary medicine. As the market continues to grow, driven by a combination of consumer demand, technological advancements, and regulatory support, the future of animal drug compounding promises to enhance the quality of care for animals, ensuring their health and well-being.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Animal Type

• Companion Animals
• Livestock Animals

By Drug Type

• Anti-Infective Agents
• Anti-Inflammatory Agents
• Hormones & Substitutes
• CNS Agents
• Other Drug Types

By Dosage Form

• Oral (Tablets, Capsules, Liquids, Other Oral Dosage Forms)
• Topical (Ointments, Creams, Gels, Sprays)
• Injectable
• Other Dosage Forms

By Distribution Channel

• Veterinary Hospitals Pharmacies
• Compounding Pharmacies
• Other Distribution Channels

COMPANIES PROFILED

• AVRIO Pharmacy, New Era Pharmacy, NexGen Pharmaceuticals, Pace Pharmacy, SaveWay Compounding Pharmacy, ScriptWorks, SCIRx Pharmacy, Summit Veterinary Pharmacy Ltd, Triangle Compounding Pharmacy, The Pet Apothecary, Veterinary Pharmaceutical Solutions, Veterinary Specialty Pharmacy, Wedgewood Pharmacy

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ANIMAL DRUG COMPOUNDING MARKET: BY ANIMAL TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Animal Type
• 4.2. Companion Animals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Livestock Animals Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ANIMAL DRUG COMPOUNDING MARKET: BY DRUG TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Drug Type
• 5.2. Anti-Infective Agents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Anti-Inflammatory Agents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Hormones & Substitutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. CNS Agents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Other Drug Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ANIMAL DRUG COMPOUNDING MARKET: BY DOSAGE FORM 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Dosage Form
• 6.2. Oral (Tablets, Capsules, Liquids, Other Oral Dosage Forms) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Topical (Ointments, Creams, Gels, Sprays) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Injectable Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Other Dosage Forms Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ANIMAL DRUG COMPOUNDING MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Distribution Channel
• 7.2. Veterinary Hospitals Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Compounding Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Other Distribution Channels Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL ANIMAL DRUG COMPOUNDING MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Animal Type
  • 8.2.2 By Drug Type
  • 8.2.3 By Dosage Form
  • 8.2.4 By Distribution Channel
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Animal Type
  • 8.3.2 By Drug Type
  • 8.3.3 By Dosage Form
  • 8.3.4 By Distribution Channel
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Animal Type
  • 8.4.2 By Drug Type
  • 8.4.3 By Dosage Form
  • 8.4.4 By Distribution Channel
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Animal Type
  • 8.5.2 By Drug Type
  • 8.5.3 By Dosage Form
  • 8.5.4 By Distribution Channel
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Animal Type
  • 8.6.2 By Drug Type
  • 8.6.3 By Dosage Form
  • 8.6.4 By Distribution Channel
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL ANIMAL DRUG COMPOUNDING INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 AVRIO Pharmacy
  • 10.2.2 New Era Pharmacy
  • 10.2.3 NexGen Pharmaceuticals
  • 10.2.4 Pace Pharmacy
  • 10.2.5 SaveWay Compounding Pharmacy
  • 10.2.6 ScriptWorks
  • 10.2.7 SCIRx Pharmacy
  • 10.2.8 Summit Veterinary Pharmacy Ltd
  • 10.2.9 Triangle Compounding Pharmacy
  • 10.2.10 The Pet Apothecary
  • 10.2.11 Veterinary Pharmaceutical Solutions
  • 10.2.12 Veterinary Specialty Pharmacy
  • 10.2.13 Wedgewood Pharmacy